Uncover the essentials of systemic treatment in Prostate and Renal Cancers in this video, highlighting its significance for health professionals seeking to enhance their expertise in caring for patients with these challenging conditions.

This is a RACGP CPD module with an allocated 0.5 hours of Education Activities (EA), 5 hours of Measuring Outcomes (MO), and 1 hour of Reflective Practice (RP) under the RACGP 2023-25 CPD program.

Learning Objectives:

1. Review the incidence and prevalence of prostate cancer in the community
2. Discuss the pharmacology of current single and multi-therapies used in prostate cancer treatment
3. Review the incidence and prevalence of renal cell carcinoma (RCC) in the community
4. Discuss the pharmacology of current single and multi-therapies used in RCC treatment
5. Discuss the impact of side effects related to pharmaceutical therapies on patients’ quality of life and how to manage in the community with prostatic and RCC

This activity is presented by Dr Tania Moujaber, a Medical Oncologist at the Norwest Private Hospital.